<p>Incidence of diabetes in mice treated with different doses of paquinimod (mg/kg/day; n = 10 for each dose) or vehicle (Ctrl; n = 20) from 10 to 20w of age A) or 15 to 38 w of age B). In the experiment in C) and D) NOD mice were treated with 1mg/kg/day of paquinimod or vehicle starting at 15w of age and two groups of mice (treated n = 10; controls n = 10) were sacrificed after 5 weeks of treatment (20w of age) C), and two additional groups (treated n = 10; controls n = 10) were sacrificed after 15 weeks of treatment (30w of age). Incidence of diabetes in treated groups compared to the control group (**, <i>p <</i> 0.01, ***, <i>p <</i> 0.001, by Mann Whitney U test).</p
<p>Non-diabetic Female NOD mice with impaired glucose tolerance at 14 weeks of age (n=24/group) were...
<p>Adoptive transfer experiments: <i>RAG<sup>−/−</sup></i> NOD mice were injected i.v. with 10<sup>7...
<p>NOD mice were injected with 50 and 100 µg MAb 8E6G4, presented as black circles and squares, resp...
Quinoline-3-carboxamides (Q compounds) are immunomodulatory compounds that have shown efficacy both ...
The NOD mouse is an established model of autoimmune diabetes mellitus. Various lines of NOD mice dif...
<p>(A) We followed diabetes onset in SR-A<sup>−/−</sup> NOD mice or NOD given high-dose poly(I∶C) (3...
<p>Male control and DJ-1 KO mice at 12–13 weeks of age were treated with 40 mg STZ/kg body weight on...
9-week old female NOD mice were injected with 100 μg islet Ag-KLH (i.v.) and, on day 4 and 8, 0.5 mg...
<p>(A) Ponesimod was administered to 6- (n = 23), 10- (n = 16), 13- (n = 16) or 16-week old (n = 15)...
<p>Four-week old female NOD mice were injected intraperitoneally with FhES (10 µg in 100 µl sterile ...
<p>Non-diabetic female NOD mice (n=33-34/group) at 12 weeks of age were administered ISO-092 or vehi...
<p>(A) Ten day-old female NOD mice were treated with an antibody against GITR. Mice having received ...
<p>NOD mice were orally administered 2×10<sup>9</sup> CFU of the corresponding recombinant <i>L. lac...
<p>Groups (n = 20) of 13-week-old NOD female mice received five i.n. administrations (every other da...
<p>The figure shows a Kaplan-Meier curve of the diabetes incidence for four groups of mice. DNCB-rep...
<p>Non-diabetic Female NOD mice with impaired glucose tolerance at 14 weeks of age (n=24/group) were...
<p>Adoptive transfer experiments: <i>RAG<sup>−/−</sup></i> NOD mice were injected i.v. with 10<sup>7...
<p>NOD mice were injected with 50 and 100 µg MAb 8E6G4, presented as black circles and squares, resp...
Quinoline-3-carboxamides (Q compounds) are immunomodulatory compounds that have shown efficacy both ...
The NOD mouse is an established model of autoimmune diabetes mellitus. Various lines of NOD mice dif...
<p>(A) We followed diabetes onset in SR-A<sup>−/−</sup> NOD mice or NOD given high-dose poly(I∶C) (3...
<p>Male control and DJ-1 KO mice at 12–13 weeks of age were treated with 40 mg STZ/kg body weight on...
9-week old female NOD mice were injected with 100 μg islet Ag-KLH (i.v.) and, on day 4 and 8, 0.5 mg...
<p>(A) Ponesimod was administered to 6- (n = 23), 10- (n = 16), 13- (n = 16) or 16-week old (n = 15)...
<p>Four-week old female NOD mice were injected intraperitoneally with FhES (10 µg in 100 µl sterile ...
<p>Non-diabetic female NOD mice (n=33-34/group) at 12 weeks of age were administered ISO-092 or vehi...
<p>(A) Ten day-old female NOD mice were treated with an antibody against GITR. Mice having received ...
<p>NOD mice were orally administered 2×10<sup>9</sup> CFU of the corresponding recombinant <i>L. lac...
<p>Groups (n = 20) of 13-week-old NOD female mice received five i.n. administrations (every other da...
<p>The figure shows a Kaplan-Meier curve of the diabetes incidence for four groups of mice. DNCB-rep...
<p>Non-diabetic Female NOD mice with impaired glucose tolerance at 14 weeks of age (n=24/group) were...
<p>Adoptive transfer experiments: <i>RAG<sup>−/−</sup></i> NOD mice were injected i.v. with 10<sup>7...
<p>NOD mice were injected with 50 and 100 µg MAb 8E6G4, presented as black circles and squares, resp...